FDA-CMS Parallel Review Saves Time, Clinical Trial Costs, Participant Says
This article was originally published in The Gray Sheet
Executive Summary
Exact Sciences, one of the first companies to volunteer for a pilot program launched in 2011 testing FDA-CMS parallel review, says its experience with the process so far is very positive. Agency officials are planning to review experiences with the program to make improvements.